학술논문

Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer
Document Type
Article
Source
In Annals of Oncology September 2021 32(9):1148-1156
Subject
Breast tumors
Language
ISSN
0923-7534